COVID-19 X-ray Diagnostics | Trivitron Healthcare
- As the COVID-19 pandemic continues, medical imaging, including X-ray technology, remains a critical tool for diagnosis and assessment.
- Navjot Singh, President – Medical Imaging, Trivitron Healthcare, highlighted the importance of X-ray imaging in the COVID-19 assessment.
- Although chest X-rays have lower sensitivity (25% to 69%) compared to other imaging techniques, their specificity—the ability to correctly identify the absence of the disease—can reach up to...
X-ray imaging is still vital in teh fight against COVID-19. Trivitron Healthcare explains how chest X-rays offer crucial insights into lung changes, especially for patients with advanced symptoms. While RT-PCR tests remain the primary detection method, X-rays offer unique benefits that make them an invaluable tool. Learn how the technology is applied to reduce viral transmission, with mobile X-ray units. The key is timing: Findings may not be evident early on; though,they become more apparent as the infection progresses. News Directory 3 notes how this technology contributes to cost-effective data storage. Ready to take an even closer look at the role of X-rays? Discover what’s next for COVID-19 diagnostics.
X-Ray Imaging plays a Key Role in COVID-19 Diagnosis
updated June 09, 2025
As the COVID-19 pandemic continues, medical imaging, including X-ray technology, remains a critical tool for diagnosis and assessment. While real-time polymerase chain reaction (RT-PCR) tests are the primary method for detecting the SARS-CoV-2 virus, X-ray imaging offers unique advantages, especially in specific clinical scenarios.
Navjot Singh, President – Medical Imaging, Trivitron Healthcare, highlighted the importance of X-ray imaging in the COVID-19 assessment. The infection, caused by the SARS-CoV-2 virus, leads to respiratory distress and spreads easily.
Although chest X-rays have lower sensitivity (25% to 69%) compared to other imaging techniques, their specificity—the ability to correctly identify the absence of the disease—can reach up to 90%. The timing of the X-ray in relation to the onset of symptoms is crucial. Findings may not be evident within the first three days of symptoms but become more apparent after 10 to 12 days.
Common X-ray findings in COVID-19 patients include consolidation (fluid accumulation in the lungs), ground-glass opacity, and nodular shadowing, primarily affecting the peripheral and lower lung areas.
While computed tomography (CT) scans are often preferred,X-ray technology offers practical benefits. X-ray equipment is easier to disinfect,reducing the risk of contamination. Moreover, mobile X-ray units, such as Kiran’s Ultisys 3.5,can be brought directly to a patient’s bedside,minimizing the potential for viral transmission.
The integration of Picture Archiving and Communication Systems (PACS) with X-ray units allows for cost-effective data storage and transmission, further reducing human exposure.
What’s next
Medical societies continue to refine guidelines for imaging in COVID-19.While chest X-rays may be less sensitive in the early stages, they remain valuable for examining quarantined patients with advanced symptoms, aiding in diagnosis and management.